Trajectory Smoothing for Guiding Aortic Valve Delivery with Transapical Access

2016 ◽  
pp. 44-51 ◽  
Author(s):  
Mustafa Bayraktar ◽  
Sertan Kaya ◽  
Erol Yeniaras ◽  
Kamran Iqbal
Keyword(s):  
Aortic Valve ◽  
Transapical Access

scholarly journals Alternate Access for TAVI: Stay Clear of the Chest

2018 ◽  
Vol 13 (3) ◽  
pp. 145 ◽  
Author(s):  
Pavel Overtchouk ◽  
Thomas Modine ◽  
◽  
Keyword(s):  
Aortic Valve ◽  
Learning Curve ◽  
Transcatheter Aortic Valve Implantation ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Poor Outcomes ◽  
Valve Implantation ◽  
Transapical Access ◽  
Experimental Stage ◽  
Existing Data

Transcatheter aortic valve implantation (TAVI) is currently performed through an alternative access in 15 % of patients. The transapical access is progressively being abandoned as a result of its invasiveness and poor outcomes. Existing data does not allow TAVI operators to favour one access over another — between transcarotid, trans-subclavian and transaortic — because all have specific strengths and weaknesses. The percutaneous trans-subclavian access might become the main surgery-free alternative access, although further research is needed regarding its safety. Moreover, the difficult learning curve might compromise its adoption. The transcaval access is at an experimental stage and requires the development of dedicated cavo-aortic crossing techniques and closure devices.

scholarly journals Transapical Deployment of Thoracic Stent Graft for Ascending Aorta Coronary Bypass Pseudoaneurysm in a Patient with Prosthetic Aortic Valve

Aorta ◽  
2019 ◽  
Vol 07 (01) ◽  
pp. 029-032
Author(s):  
Michele Antonello ◽  
Augusto D'Onofrio ◽  
Marco Zavatta ◽  
Giambattista Isabella ◽  
Carlo Maturi ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Saphenous Vein Graft ◽  
Artery Bypass ◽  
Coronary Bypass ◽  
Percutaneous Transluminal Coronary Angioplasty ◽  
Prosthetic Aortic Valve ◽  
Anastomotic Pseudoaneurysm ◽  
Complete Exclusion ◽  
Transluminal Coronary Angioplasty ◽  
Transapical Access

AbstractThe authors describe the transapical deployment of a thoracic endograft to exclude a saphenous vein graft proximal anastomotic pseudoaneurysm following coronary artery bypass grafting (CABG) in a 63-year-old male with a prosthetic aortic valve. A standard thoracic endograft has been deployed via transapical access after percutaneous transluminal coronary angioplasty of the native vessel perfused by the patent CABG. The procedure was uneventful; an 8-month computed tomography scan showed complete exclusion of the pseudoaneurysm with patency of supra-aortic trunks.

scholarly journals The first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”

2018 ◽  
pp. 50-57
Author(s):  
A. V. Bogachev-­Prokofiev ◽  
R. M. Sharifulin ◽  
D. D. Zubarev ◽  
A. M. Karaskov
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Valve Prosthesis ◽  
Routine Procedure ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Prosthesis ◽  
Aortal Valve ◽  
Transapical Access

Aim.Transcatheter aortic valve replacement in patients with high and extremely high risk has become a routine procedure in many cardiac surgery clinics. Until recently, there were no transcatheter prostheses produced within Russia. This article analyzes the results of applying the first domestic transcatheter aortic valve prosthesis MedLab­KT.Material and methods.In the period from June 2018 to October 2018, 7 operations of transcatheter aortic valve replacement were made using the MedLabKT prosthesis. In all cases, implantation was performed by transapical access.Results.We noted one death. In all cases, paraprosthetic regurgitation was not registrated or was not significant. There are no cases of dislocation of the prosthesis. There were no complications associated with access. In one case, implantation was complicated by myocardial infarction.Conclusion.The first experience of implantation demonstrated the efficacy and safety of using the MedLab­LT prosthesis for transcatheter aortic valve replacement. The analysis of long­term results is required.

scholarly journals The first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”

2018 ◽  
pp. 50-56
Author(s):  
A. V. Bogachev-­Prokofiev ◽  
R. M. Sharifulin ◽  
D. D. Zubarev ◽  
A. M. Karaskov
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Valve Prosthesis ◽  
Routine Procedure ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Prosthesis ◽  
Aortal Valve ◽  
Transapical Access

Aim. Transcatheter aortic valve replacement in patients with high and extremely high risk has become a routine procedure in many cardiac surgery clinics. Until recently, there were no transcatheter prostheses produced within Russia. This article analyzes the results of applying the first domestic transcatheter aortic valve prosthesis MedLab­KT. Material and methods. In the period from June 2018 to October 2018, 7 operations of transcatheter aortic valve replacement were made using the MedLabKT prosthesis. In all cases, implantation was performed by transapical access.Results. We noted one death. In all cases, paraprosthetic regurgitation was not registrated or was not significant. There are no cases of dislocation of the prosthesis. There were no complications associated with access. In one case, implantation was complicated by myocardial infarction.Conclusion. The first experience of implantation demonstrated the efficacy and safety of using the MedLab­LT prosthesis for transcatheter aortic valve replacement. The analysis of long­term results is required.

Sign in / Sign up

Export Citation Format

Share Document